These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 21554421)
21. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). Lortholary O; Fernández-Ruiz M; Perfect JR J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the significance of molecular methods in the diagnosis of invasive fungal infections: comparison with conventional methods]. Susever S; Yeğenoğlu Y Mikrobiyol Bul; 2011 Apr; 45(2):325-35. PubMed ID: 21644076 [TBL] [Abstract][Full Text] [Related]
23. [Invasive fungal infections in children: similarities and differences with adults]. Ramos JT; Francisco L; Daoud Z Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():59-65. PubMed ID: 27608317 [TBL] [Abstract][Full Text] [Related]
24. Does the current treatment of invasive fungal infection need to be reviewed? Martín-Peña A; Aguilar-Guisado M; Cisneros JM Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):523-8. PubMed ID: 23587702 [TBL] [Abstract][Full Text] [Related]
25. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680 [TBL] [Abstract][Full Text] [Related]
26. Update on antifungal treatment of invasive Candida and Aspergillus infections. Maschmeyer G; Ruhnke M Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398 [TBL] [Abstract][Full Text] [Related]
28. Current diagnostic approaches to invasive candidiasis in critical care settings. Pemán J; Zaragoza R Mycoses; 2010 Sep; 53(5):424-33. PubMed ID: 19627506 [TBL] [Abstract][Full Text] [Related]
29. Current and future therapies for invasive aspergillosis. Bassetti M; Pecori D; Della Siega P; Corcione S; De Rosa FG Pulm Pharmacol Ther; 2015 Jun; 32():155-65. PubMed ID: 24994691 [TBL] [Abstract][Full Text] [Related]
30. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300 [TBL] [Abstract][Full Text] [Related]
31. Prevention of fungal infections in the immunocompromised host. Mahfouz T; Anaissie E Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882 [TBL] [Abstract][Full Text] [Related]
32. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study. Hoenigl M; Prattes J; Neumeister P; Wölfler A; Krause R Mycoses; 2018 Mar; 61(3):201-205. PubMed ID: 29112326 [TBL] [Abstract][Full Text] [Related]
33. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Leather HL; Wingard JR Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028 [TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of invasive fungal diseases in neutropenic patients. Almyroudis NG; Segal BH Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476 [TBL] [Abstract][Full Text] [Related]
35. Invasive Fungal Infections in the Intensive Care Unit. Ostrosky-Zeichner L; Al-Obaidi M Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215 [TBL] [Abstract][Full Text] [Related]
36. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis. Danpornprasert P; Foongladda S; Tscheikuna J J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562 [TBL] [Abstract][Full Text] [Related]
37. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791 [TBL] [Abstract][Full Text] [Related]
38. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989 [TBL] [Abstract][Full Text] [Related]
39. [Invasive fungal infections in patients after liver transplantation]. Fischer L; Sterneck M Mycoses; 2005; 48 Suppl 1():27-35. PubMed ID: 15826284 [TBL] [Abstract][Full Text] [Related]
40. [Prevention of fungal infections in children and adolescents with cancer]. Groll AH; Ritter J; Müller FM Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]